Patent · US Active

Dosage form for hormonal contraception

US8119620B2 · kind B2 · utility

2Cited by

1References

15Claims

0Family size

Assignee

Gruenenthal GmbH · DE

Inventors

Georg Schramm · Stolberg, DE
Eric-Paul Paques · Marburg, DE

Key dates

Filing date	May 9, 2008
Grant date	Feb 21, 2012
Priority date	—
Expiry date	Dec 1, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A dosage form for hormonal contraception containing a specific number of gestagen-containing daily units A and a specific number of gestagen-containing daily units B for uninterrupted, daily, oral administration of daily units A and then immediately subsequently of daily units B, wherein the daily units A in each case contain at most 200 μg of folic acid and the daily units B contain >200 μg up to the maximum permissible amount of folic acid for women.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.